
        <html>
        <head>
            <style>
                body { font-family: Arial, sans-serif; line-height: 1.6; margin: 20px; }
                h3 { color: #333; }
                .question { margin-bottom: 15px; }
                .options { margin-left: 20px; margin-bottom: 10px; }
                .solution { background: #f8f9fa; padding: 10px; border-left: 4px solid #007bff; }
                .credits { text-align: center; margin-top: 20px; font-size: 18px; }
                .rainbow-text { 
                    background: linear-gradient(90deg, red, orange, yellow, green, blue, indigo, violet); 
                    -webkit-background-clip: text; 
                    color: transparent; 
                    font-weight: bold; 
                }
            </style>
        </head>
        <body>
        
            <div class="question">
                <h3>Question No: 1</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the following diseases with their respective mode of inheritance.</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 45.3933%;" width="265">
<p><strong>Column-A</strong></p>
</td>
<td style="width: 54.6067%;" width="321">
<p><strong>Column-B</strong></p>
</td>
</tr>
<tr>
<td style="width: 45.3933%;" width="265">
<p>1)&nbsp;&nbsp;&nbsp; Cystic Fibrosis</p>
<p>2)&nbsp;&nbsp;&nbsp; Duchenne Muscular Dystrophy</p>
<p>3)&nbsp;&nbsp;&nbsp; Optic Neuritis</p>
<p>4)&nbsp;&nbsp;&nbsp; Marfan Syndrome</p>
</td>
<td style="width: 54.6067%;" width="321">
<p>A.&nbsp;&nbsp; Mitochondrial Inheritance</p>
<p>B.&nbsp;&nbsp;&nbsp; Autosomal Recessive</p>
<p>C. &nbsp; Autosomal dominant</p>
<p>D.&nbsp;&nbsp; X-Linked Recessive</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-D, 2-C, 3-B, 4-A</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-B 2-D, 3-A, 4-C</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-B, 2-C, 3-A, 4-D</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-D, 2-C, 3-B, 4-A</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong><u>Mitochondrial Inheritance</u></strong><strong> </strong></p>
<ul>
<li>Mother transmits disorder (maternal inheritance) to all her children but females may show signs of disease.</li>
<li>Variable expression in a population or even within a family is due to heteroplasmy.</li>
<li><strong>Heteroplasmy:</strong> Phenomenon where cells have variable proportion of normal and mutant mtDNA in their organelle is known as heteroplasmy.</li>
</ul>
<p><img title="image001.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/ba43cd17-e87f-4b3d-b7f5-af21872b51b1.jpg" alt="" width="250" height="199" /></p>
<p><img title="image002.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/0a3559c2-cb94-442d-bed9-f227ec13dd05.jpg" alt="" width="453" height="25" /></p>
<p><strong>Fig: Mitochondrial inheritance pedigree&nbsp; </strong></p>
<p><strong>&nbsp;</strong></p>
<p><strong>Examples: </strong></p>
<ul>
<li>Most common mitochondrial inheritance is <strong>MELAS syndrome</strong> (mitochondrial encephalopathy, lactic acidosis, and stroke like syndrome).</li>
<li><strong>Leber herediatary optic neuropathy </strong></li>
<li>NARP (neurogenic weakness, ataxia and retinitis pigmentosa)</li>
<li>Leigh&rsquo;s syndrome</li>
<li>CPEO (Chronic progressive external opthalmoplegia)</li>
<li>Kearns-Sayre syndrome</li>
</ul>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 49.2135%;" width="375">
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><u>X linked Dominant</u> </strong></p>
<ul>
<li>Rare pattern of inheritance</li>
<li>Affected male will transmit it <strong>100% to their daughters</strong> and none of their sons.</li>
<li>Affected (diseased) female will transmit the disease 50% to their sons and daughters.</li>
<li><strong>Examples: </strong></li>
</ul>
<ul>
<li style="list-style-type: none;">
<ul style="list-style-type: square;">
<li>&ldquo;Red Rose for all children&rdquo;</li>
<li>Red: X-linked hypophosphatemic Rickets</li>
<li>Rose: Rett&rsquo;s syndrome</li>
<li>For: Fragile X syndrome (XR &gt; XD)</li>
<li>All: Alport syndrome</li>
<li>Children : Charcot&ndash;Marie&ndash;Tooth disease</li>
</ul>
</li>
</ul>
</td>
<td style="width: 48.427%;" width="369">
<p>&nbsp;<img title="image003.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/70766948-3ca0-4df7-be17-c58c650c8072.jpg" alt="" width="288" height="228" /></p>
</td>
<td style="width: 2.24719%;" width="2">
<p>&nbsp;</p>
</td>
</tr>
<tr>
<td style="width: 49.2135%;" width="375">
<p><strong>&nbsp; <u>Autosomal dominant inheritance</u> </strong></p>
<ul>
<li>Most common pattern of Mendelian inheritance.</li>
<li>They manifest disease in the heterozygous state, so at least one parent of index case is usually affected.</li>
<li>Most commonly due to defects in structural genes.&nbsp;</li>
<li>Many generations, both males and females are affected.</li>
<li><strong>Examples:</strong></li>
</ul>
<ul>
<li style="list-style-type: none;">
<ul style="list-style-type: square;">
<li>Achondroplasia</li>
<li>Autosomal dominant polycystic kidney disease</li>
<li>Familial adenomatous polyposis</li>
<li>Familial hypercholesterolemia</li>
<li>Hereditary hemorrhagic telangiectasia</li>
<li>Hereditary spherocytosis</li>
<li>Huntington disease</li>
<li>Li-Fraumeni syndrome</li>
<li>Marfan syndrome</li>
<li>Multiple endocrine neoplasia</li>
<li>Neurofibromatosis type 1 (von Recklinghausen disease)</li>
<li>Neurofibromatosis type 2</li>
<li>Tuberous sclerosis,</li>
<li>Von Hippel-Lindau disease</li>
</ul>
</li>
</ul>
</td>
<td style="width: 48.427%;" width="369">
<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<img title="image004.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/887cd86f-e3ea-4554-b759-d3b46862bbf9.jpg" alt="" width="280" height="235" /></p>
</td>
<td style="width: 2.24719%;" width="2">
<p>&nbsp;</p>
</td>
</tr>
<tr>
<td style="width: 49.2135%;" width="375">
<p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>X linked Recessive</u> (XLR)</strong></p>
<ul>
<li>Most common pattern of sex-linked disorders is X-linked recessive.</li>
<li><strong>Commonly males are affected</strong>; because mutant genes on the X-chromosome do not have a Y-chromosome counterpart (affected males are hemizygous for the X-linked mutant gene).</li>
<li>Heterozygote, males are not affected usually due to a paired normal Xallele.</li>
<li>Female can be affected when there is random X inactivation in cells population.</li>
<li><strong>Example: -&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></li>
</ul>
<ul>
<li style="list-style-type: none;">
<ul style="list-style-type: square;">
<li><strong>O</strong>rnithine transcarbamylase deficiency</li>
<li><strong>F</strong>abry disease</li>
<li><strong>W</strong>iskott-Aldrich syndrome</li>
<li><strong>O</strong>cular albinism</li>
<li><strong>G</strong>6PD deficiency</li>
<li><strong>H</strong>unter syndrome</li>
<li><strong>B</strong>ruton agammaglobulinemia</li>
<li><strong>H</strong>emophilia A and B</li>
<li><strong>L</strong>esch-Nyhan syndrome</li>
<li><strong>D</strong>uchenne (and Becker) muscular dystrophy. &nbsp;&nbsp;&nbsp;</li>
</ul>
</li>
</ul>
<p><strong><u>Mnemonics:</u></strong><strong> Oblivious Female Will </strong></p>
<p><strong>Often Give Her Boys Her Linked Disorders</strong></p>
</td>
<td style="width: 48.427%;" width="369">
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;<img title="image005.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/e7de50a1-3c87-4b08-982b-6c5485efedf4.png" alt="" width="250" height="238" /></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
</td>
<td style="width: 2.24719%;" width="2">
<p>&nbsp;</p>
</td>
</tr>
<tr>
<td style="width: 49.2135%;" width="375">
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><u>Autosomal recessive</u></strong></p>
<ul>
<li>Most of the inborn errors of metabolism are autosomal recessive. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>Usually seen in only 1 generation. &nbsp;</li>
<li>With 2 carrier (heterozygous) parents, on average:
<ul style="list-style-type: square;">
<li>&frac14; of children will be affected (homozygous),</li>
<li>&frac12; of children will be carriers,</li>
<li>&frac14; of children will be neither affected nor carriers.</li>
</ul>
</li>
<li><strong>Examples:</strong></li>
</ul>
<ul>
<li style="list-style-type: none;">
<ul style="list-style-type: square;">
<li>Albinism</li>
<li>Autosomal recessive polycystic kidney disease (ARPKD)</li>
<li>Cystic fibrosis</li>
<li>Glycogen storage diseases</li>
<li>Hemochromatosis</li>
<li>Kartagener syndrome</li>
<li>Mucopolysaccharidoses (except Hunter syndrome)</li>
<li>Phenylketonuria</li>
<li>Sickle cell anemia</li>
<li>Sphingolipidoses (except Fabry disease)</li>
<li>Thalassemia</li>
<li>Wilson disease</li>
</ul>
</li>
</ul>
</td>
<td style="width: 50.6742%;" colspan="2" width="371">
<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<img title="image006.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/57f5640a-0b44-4b9d-98aa-451326237043.jpg" alt="" width="250" height="254" /></p>
</td>
</tr>
</tbody>
</table>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 2</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the following tumors with respective to their marker.</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 52.1348%;" width="316">
<p><strong>Column-A</strong></p>
</td>
<td style="width: 47.8652%;" width="289">
<p><strong>Column-B</strong></p>
</td>
</tr>
<tr>
<td style="width: 52.1348%;" width="316">
<p>1)&nbsp;&nbsp;&nbsp; Choriocarcinoma</p>
<p>2)&nbsp;&nbsp;&nbsp; Medullary thyroid carcinoma</p>
<p>3)&nbsp;&nbsp;&nbsp; Pheochromocytoma</p>
<p>4)&nbsp;&nbsp;&nbsp; Hepatocellular carcinoma</p>
</td>
<td style="width: 47.8652%;" width="289">
<p>A.&nbsp;&nbsp; AFP</p>
<p>B.&nbsp;&nbsp;&nbsp; &beta;-hCG</p>
<p>C.&nbsp;&nbsp;&nbsp; Catecholamine/Metanephrine</p>
<p>D.&nbsp;&nbsp; Calcitonin</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-D, 2-A, 3-B, 4-C</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-B, 2-D, 3-C, 4-A</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-C, 2-D, 3-A, 4-B</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-D, 2-C, 3-B, 4-A</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Tumor Markers </strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 54.9438%;" colspan="2" width="378">
<p><strong>Tumor Markers</strong></p>
</td>
<td style="width: 45.0562%;" width="319">
<p><strong>Tumor Types</strong></p>
</td>
</tr>
<tr>
<td style="width: 17.9775%;" rowspan="3" width="119">
<p>Hormones</p>
</td>
<td style="width: 36.9663%;" width="259">
<p><strong>Human chorionic gonadotropin (hCG</strong>)</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Trophoblastic tumors, non-seminonmatous and testicular tumors, <strong>Choriocarcinoma</strong></p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p><strong>Calcitonin</strong></p>
</td>
<td style="width: 45.0562%;" width="319">
<p><strong>Medullary carcinoma of thyroid</strong></p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p><strong>Catecholamine</strong> and metabolites</p>
</td>
<td style="width: 45.0562%;" width="319">
<p><strong>Pheochromocytoma </strong>and related tumors</p>
<p>Paraganglioma</p>
<p>Neuroblastoma</p>
</td>
</tr>
<tr>
<td style="width: 17.9775%;" rowspan="2" width="119">
<p>Oncofetal Antigens</p>
</td>
<td style="width: 36.9663%;" width="259">
<p><strong>&alpha;-Fetoprotein (AFP)</strong></p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Liver cell cancer, non-seminonmatous germ-celli tumors of the testis, <strong>Hepatoblastoma</strong></p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>Carcinoembryonic antigen (CEA)</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Carcinomas of the colon, lung, stomach, and heart</p>
</td>
</tr>
<tr>
<td style="width: 17.9775%;" rowspan="8" width="119">
<p>Enzymes</p>
</td>
<td style="width: 36.9663%;" width="259">
<p>Prostatic acid phosphatase</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Prostate cancer</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>Neuron-specific enolase (NSE)</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Small-cell cancer of the lung, neuroblastoma</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>Lactate dehydrogenase (LDH)</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Prostate carcinoma, testicular tumors, lymphoma, Ewing&rsquo;s sarcoma (Bone tumor) and leukemias</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>Thymidine kinase</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Leukemias</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>Tyrosine</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Melanoma</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>Gastrin</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Pancreatic neuroendocrine tumor (Gastrinoma, ZES)</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>Pyruvate kinase</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Renal cell carcinoma</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>Placental alkaline phosphatase</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Seminoma</p>
</td>
</tr>
<tr>
<td style="width: 17.9775%;" rowspan="4" width="119">
<p>Specific Proteins</p>
</td>
<td style="width: 36.9663%;" width="259">
<p>Immunoglobulins (Ig)</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Multiple myeloma and other gammopathies</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>Beta 2 microglobulin (&beta;2M)</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Multiple myeloma</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>Prostate-specific antigen (PSA) and prostate- specific membrane antigen</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Prostate cancer</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>NMP 22</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Bladder cancer</p>
</td>
</tr>
<tr>
<td style="width: 17.9775%;" rowspan="5" width="119">
<p>Mucins and other glycoproteins</p>
</td>
<td style="width: 36.9663%;" width="259">
<p>CA-125</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Ovarian cancer</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>CA- 19-9</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Colon cancer, pancreatic cancer</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>CA-15-3</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Breast cancer</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>CA-72-4</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Gastric carcinoma</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>CD 25</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Hairy cell leukemia and lymphoma</p>
</td>
</tr>
<tr>
<td style="width: 17.9775%;" rowspan="4" width="119">
<p>Cell-Free DNA markers</p>
</td>
<td style="width: 36.9663%;" width="259">
<p>TP53, APC, RAS mutants in stool and serum</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Colon cancer</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>TP53, RAS mutants in stool and serum</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Pancreatic cancer</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>TP53, RAS mutants in sputum and serum</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Lung cancer</p>
</td>
</tr>
<tr>
<td style="width: 36.9663%;" width="259">
<p>TP53 mutants in urine</p>
</td>
<td style="width: 45.0562%;" width="319">
<p>Bladder cancer</p>
</td>
</tr>
</tbody>
</table>
<p>NMP: Nuclear matrix protein, CA: Carbohydrate antigen</p>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 3</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the acid-base imbalances with their mechanisms.</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 50%;" width="293">
<p><strong>Column-A </strong></p>
</td>
<td style="width: 50%;" width="293">
<p><strong>Column-B </strong></p>
</td>
</tr>
<tr>
<td style="width: 50%;" width="293">
<p>A.&nbsp;&nbsp; Increased carbonic acid (H<sub>2</sub>CO<sub>3</sub>)</p>
<p>B.&nbsp;&nbsp;&nbsp; Decreased carbonic acid (H<sub>2</sub>CO<sub>3</sub>)</p>
<p>C.&nbsp;&nbsp;&nbsp; Increased base bicarbonate (HCO<sub>3</sub><sup>&ndash;</sup>)</p>
<p>D.&nbsp;&nbsp; Decreased base bicarbonate (HCO<sub>3</sub><sup>&ndash;</sup>)</p>
</td>
<td style="width: 50%;" width="293">
<p>1)&nbsp;&nbsp;&nbsp; Metabolic acidosis</p>
<p>2)&nbsp;&nbsp;&nbsp; Metabolic alkalosis</p>
<p>3)&nbsp;&nbsp;&nbsp; Respiratory acidosis</p>
<p>4)&nbsp;&nbsp;&nbsp; Respiratory alkalosis</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-4, B-3, C-2, D-1</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-3, B-4, C-2, D-1</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-3, B-4, C-1, D-2</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-4, B-3, C-1, D-2</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li><strong>Increased carbonic acid - H₂CO₃</strong>: This corresponds to <strong>respiratory acidosis</strong>, where impaired lung function leads to carbon dioxide retention, causing an increase in carbonic acid levels.</li>
<li><strong>Decreased carbonic acid - H₂CO₃</strong>: This describes <strong>respiratory alkalosis</strong>, which occurs when excessive breathing (hyperventilation) reduces carbon dioxide levels, leading to decreased carbonic acid.</li>
<li><strong>Increased bicarbonate - HCO₃⁻</strong>: This is associated with <strong>metabolic alkalosis</strong>, where elevated bicarbonate levels are often due to excessive loss of acids (e.g., through vomiting) or bicarbonate retention.</li>
<li><strong>Decreased bicarbonate - HCO₃⁻</strong>: This represents <strong>metabolic acidosis</strong>, where bicarbonate is depleted, often due to conditions like diarrhea, renal failure, or lactic acid accumulation.</li>
</ul>
<p><strong>Key Insight:</strong><br />Respiratory imbalances involve changes in <strong>carbonic acid</strong> (related to CO₂ levels), while metabolic imbalances involve changes in <strong>bicarbonate</strong> levels.</p>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 4</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the diseases with their maximum incubation period.</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 43.3708%;" width="236">
<p><strong>Diseases</strong></p>
</td>
<td style="width: 56.6292%;" width="312">
<p><strong>Incubation period</strong></p>
</td>
</tr>
<tr>
<td style="width: 43.3708%;" width="236">
<p>1)&nbsp;&nbsp;&nbsp; Hepatitis A</p>
<p>2)&nbsp;&nbsp;&nbsp; Chickenpox</p>
<p>3)&nbsp;&nbsp;&nbsp; SARS</p>
<p>4)&nbsp;&nbsp;&nbsp; Syphilis</p>
</td>
<td style="width: 56.6292%;" width="312">
<p>a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 days</p>
<p>b.&nbsp;&nbsp;&nbsp;&nbsp; 90 days</p>
<p>c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 21 days</p>
<p>d.&nbsp;&nbsp;&nbsp;&nbsp; 50 days</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-a, 2-b, 3-c, 4-d</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-d, 2-c, 3-b, 4-a</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-d, 2-c, 3-a, 4-b</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-b, 2-a, 3-d, 4-c</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>The correct match is:</p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 39.3258%;" width="142">
<p><strong>Diseases</strong></p>
</td>
<td style="width: 60.6742%;" width="227">
<p><strong>Incubation period</strong></p>
</td>
</tr>
<tr>
<td style="width: 39.3258%;" width="142">
<p>1. Hepatitis A</p>
</td>
<td style="width: 60.6742%;" width="227">
<p>d. 50 days</p>
</td>
</tr>
<tr>
<td style="width: 39.3258%;" width="142">
<p>2. Chickenpox</p>
</td>
<td style="width: 60.6742%;" width="227">
<p>c. 21 days</p>
</td>
</tr>
<tr>
<td style="width: 39.3258%;" width="142">
<p>3. SARS-CoV-2</p>
</td>
<td style="width: 60.6742%;" width="227">
<p>a. 10 days</p>
</td>
</tr>
<tr>
<td style="width: 39.3258%;" width="142">
<p>4. Syphilis</p>
</td>
<td style="width: 60.6742%;" width="227">
<p>b. 90 days &nbsp;&nbsp;</p>
</td>
</tr>
</tbody>
</table>
<p>The <strong>incubation period</strong> is the time interval between the invasion of the infectious agent and the appearance of the first symptom or signs in the body.</p>
<ul>
<li>The incubation period of <strong>syphilis</strong> is <strong>10-90</strong> days and varies inversely with the size of the Spirochete inoculum.</li>
<li>The incubation period of <strong>SARS</strong> infection ranges from <strong>5 to 10 days</strong>.</li>
<li>The incubation period of <strong>Hepatitis A</strong> infection ranges from <strong>10 to 50 days (</strong>usually 14-28 days). &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li><strong>Chickenpox i</strong>s caused by varicella zoster virus (HSV-3). The incubation period is between <strong>10 to 21 days. </strong></li>
</ul>
<p><strong>Incubation period of important viral infections </strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 46.7416%;" width="189">
<p><strong>Viral infection</strong></p>
</td>
<td style="width: 53.2584%;" width="217">
<p><strong>Incubation period</strong></p>
</td>
</tr>
<tr>
<td style="width: 46.7416%;" width="189">
<p>Measles</p>
</td>
<td style="width: 53.2584%;" width="217">
<p>7 - 18 days</p>
</td>
</tr>
<tr>
<td style="width: 46.7416%;" width="189">
<p>Chickenpox</p>
</td>
<td style="width: 53.2584%;" width="217">
<p>14 - 21 days</p>
</td>
</tr>
<tr>
<td style="width: 46.7416%;" width="189">
<p>Mumps</p>
</td>
<td style="width: 53.2584%;" width="217">
<p>14 - 21 days</p>
</td>
</tr>
<tr>
<td style="width: 46.7416%;" width="189">
<p>Rubella</p>
</td>
<td style="width: 53.2584%;" width="217">
<p>14 - 21 days</p>
</td>
</tr>
<tr>
<td style="width: 46.7416%;" width="189">
<p>Erythema infectiosum</p>
</td>
<td style="width: 53.2584%;" width="217">
<p>4 - 14 days</p>
</td>
</tr>
<tr>
<td style="width: 46.7416%;" width="189">
<p>Exanthem subitum</p>
</td>
<td style="width: 53.2584%;" width="217">
<p>5 - 15 days</p>
</td>
</tr>
<tr>
<td style="width: 46.7416%;" width="189">
<p>Infectious mononucleosis</p>
</td>
<td style="width: 53.2584%;" width="217">
<p>4 - 5 weeks</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 5</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the following vaccines to the vaccine strains.</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 43.3708%;" width="236">
<p><strong>Column-A</strong></p>
</td>
<td style="width: 56.6292%;" width="312">
<p><strong>Column-B</strong></p>
</td>
</tr>
<tr>
<td style="width: 43.3708%;" width="236">
<p>1)&nbsp;&nbsp;&nbsp; Yellow fever</p>
<p>2)&nbsp;&nbsp;&nbsp; Rubella</p>
<p>3)&nbsp;&nbsp;&nbsp; Chicken Pox</p>
<p>4)&nbsp;&nbsp;&nbsp; Japanese encephalitis</p>
</td>
<td style="width: 56.6292%;" width="312">
<p>A.&nbsp;&nbsp; 14-14-2 strain</p>
<p>B.&nbsp;&nbsp;&nbsp; 17D strain</p>
<p>C.&nbsp;&nbsp;&nbsp; RA 27/3 strain</p>
<p>D.&nbsp;&nbsp; OKA strain</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-B, 2-C, 3-A, 4-D &nbsp;</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-B, 2-A, 3-C, 4-D</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-B, 2-C, 3-D, 4-A</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-C, 2-D, 3-A, 4-B</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>The correct match is</p>
<ol>
<li>Yellow fever- B) 17D strain</li>
<li>Rubella- C) RA 27/3 strain</li>
<li>Chicken pox- D) OKA strain</li>
<li>Japanese encephalitis- A) 14-14-2 strain</li>
</ol>
<p><strong>Vaccine and their strain </strong></p>
<table style="border-collapse: collapse; width: 100%; height: 1902.74px;" border="1">
<tbody>
<tr style="height: 54.3906px;">
<td style="width: 26.2921%; height: 54.3906px;" width="180">
<p><strong>Vaccine</strong></p>
</td>
<td style="width: 73.7079%; height: 54.3906px;" width="529">
<p><strong>Strains</strong></p>
</td>
</tr>
<tr style="height: 54.3906px;">
<td style="width: 26.2921%; height: 54.3906px;" width="180">
<p>BCG</p>
</td>
<td style="width: 73.7079%; height: 54.3906px;" width="529">
<p>Danish-1331 strain</p>
</td>
</tr>
<tr style="height: 115.172px;">
<td style="width: 26.2921%; height: 115.172px;" width="180">
<p>OPV/IPV</p>
</td>
<td style="width: 73.7079%; height: 115.172px;" width="529">
<p>Bivalent OPV</p>
<ul>
<li>OPV: SABIN strain</li>
<li>IPV: SALK</li>
</ul>
</td>
</tr>
<tr style="height: 131.172px;">
<td style="width: 26.2921%; height: 131.172px;" width="180">
<p>Measles</p>
</td>
<td style="width: 73.7079%; height: 131.172px;" width="529">
<ul>
<li>Edmonston Zagreb strain</li>
<li>Schwartz strain</li>
<li>Moraten strain</li>
</ul>
</td>
</tr>
<tr style="height: 54.3906px;">
<td style="width: 26.2921%; height: 54.3906px;" width="180">
<p>Mumps</p>
</td>
<td style="width: 73.7079%; height: 54.3906px;" width="529">
<p>Jeryll-Lynn strain</p>
</td>
</tr>
<tr style="height: 54.3906px;">
<td style="width: 26.2921%; height: 54.3906px;" width="180">
<p>Rubella</p>
</td>
<td style="width: 73.7079%; height: 54.3906px;" width="529">
<p>RA 27/3</p>
</td>
</tr>
<tr style="height: 54.3906px;">
<td style="width: 26.2921%; height: 54.3906px;" width="180">
<p>Yellow fever</p>
</td>
<td style="width: 73.7079%; height: 54.3906px;" width="529">
<p>17 D strain (Live vaccine, <strong>one dose given in lifetime</strong>.</p>
</td>
</tr>
<tr style="height: 54.3906px;">
<td style="width: 26.2921%; height: 54.3906px;" width="180">
<p>Varicella (Chicken Pox)</p>
</td>
<td style="width: 73.7079%; height: 54.3906px;" width="529">
<p>OKA strain, live vaccine</p>
</td>
</tr>
<tr style="height: 131.172px;">
<td style="width: 26.2921%; height: 131.172px;" width="180">
<p>Japanese encephalitis</p>
</td>
<td style="width: 73.7079%; height: 131.172px;" width="529">
<ul>
<li>Nakayama strain</li>
<li>Beijing P3 strain</li>
<li>A-14-14-2 strain (used in India)</li>
</ul>
</td>
</tr>
<tr style="height: 54.3906px;">
<td style="width: 26.2921%; height: 54.3906px;" width="180">
<p>Swine flu vaccine</p>
</td>
<td style="width: 73.7079%; height: 54.3906px;" width="529">
<p>A7/ California / 2009</p>
</td>
</tr>
<tr style="height: 131.172px;">
<td style="width: 26.2921%; height: 131.172px;" width="180">
<p>HIV vaccine</p>
</td>
<td style="width: 73.7079%; height: 131.172px;" width="529">
<ul>
<li>mVA strain</li>
<li>rAAV strain &nbsp;</li>
<li>CTL strain</li>
</ul>
</td>
</tr>
<tr style="height: 207.938px;">
<td style="width: 26.2921%; height: 207.938px;" width="180">
<p>Malaria vaccine</p>
</td>
<td style="width: 73.7079%; height: 207.938px;" width="529">
<ul>
<li>SPf 66 strain (Lytic cocktail)</li>
<li>Pf 25 strain</li>
<li>RTS, S/AS01 is effective against P. falciparum.</li>
</ul>
<ul>
<li style="list-style-type: none;">
<ul style="list-style-type: square;">
<li>Phase 3 trial of this vaccine is complete.</li>
<li>Phase 4 trial is under evaluation.</li>
</ul>
</li>
</ul>
</td>
</tr>
<tr style="height: 131.172px;">
<td style="width: 26.2921%; height: 131.172px;" width="180">
<p>Typhoid</p>
</td>
<td style="width: 73.7079%; height: 131.172px;" width="529">
<ul>
<li>Oral typhi 21a- live vaccine.</li>
<li>Vi polysaccharide vaccine- for age &gt; 2 years.</li>
<li>Typhoid conjugate vaccine- single dose for high risk susceptible.</li>
</ul>
</td>
</tr>
<tr style="height: 54.3906px;">
<td style="width: 26.2921%; height: 54.3906px;" width="180">
<p>Meningococcal</p>
</td>
<td style="width: 73.7079%; height: 54.3906px;" width="529">
<ul>
<li>A, C, W135, Quadrivalent vaccine.</li>
</ul>
</td>
</tr>
<tr style="height: 54.3906px;">
<td style="width: 26.2921%; height: 54.3906px;" width="180">
<p>Pneumococcal</p>
</td>
<td style="width: 73.7079%; height: 54.3906px;" width="529">
<ul>
<li>Pneumococcal conjugate vaccine, Pneumococcal polysaccharide vaccine. &nbsp;</li>
</ul>
</td>
</tr>
<tr style="height: 565.422px;">
<td style="width: 26.2921%; height: 565.422px;" width="180">
<p>COVID vaccine</p>
</td>
<td style="width: 73.7079%; height: 565.422px;" width="529">
<ul>
<li><strong>Viral vector vaccines:</strong></li>
</ul>
<ul>
<li style="list-style-type: none;">
<ul style="list-style-type: square;">
<li>Covishield&mdash;using CHAD-OX1 strain, with chimpanzee adenovirus.</li>
<li>Sputnik&mdash;human adenovirus vaccine</li>
<li>Janssen&mdash;viral vectored vaccine by Johnson and Johnson.</li>
<li>INCOVACC (2022)-BBV154 nasal vaccine</li>
</ul>
</li>
<li style="list-style-type: none;">
<ul>
<li style="list-style-type: none;">
<ul style="list-style-type: circle;">
<li>Recombinant replication deficient adenovirus vectored vaccine with a perfusion stabilized spike protein</li>
<li>For age &gt;18 years, 2-dose schedule with gap of 4 weeks</li>
<li>It is the first approved nasal vaccine, produced from India (Bharat Biotech).</li>
</ul>
</li>
</ul>
</li>
<li><strong>Killed vaccine &nbsp;&nbsp;</strong></li>
<li style="list-style-type: none;">
<ul style="list-style-type: square;">
<li>Covaxin using BBV-152 strain, killed inactivated vaccine</li>
<li>Sinovac/CoronaVac&mdash;inactivated COVID-19 vaccine</li>
</ul>
</li>
<li>Protein subunit vaccine</li>
</ul>
<ul>
<li style="list-style-type: none;">
<ul style="list-style-type: square;">
<li>Novavax-Subunit Protein Vaccine</li>
<li>Corbevax&mdash;BECOV2D protein subunit strain with Alum adjuvant. &nbsp;</li>
</ul>
</li>
<li style="list-style-type: none;">
<ul style="list-style-type: circle;">
<li>Version of the receptor binding domain (RBD)</li>
<li>Recombinant subunit vaccine, for 12-14 years</li>
<li>0.5 mL, IM, 2 doses with &gt;4 weeks&rsquo; gap</li>
</ul>
</li>
<li>mRNA vaccines&mdash;Pfizer, Moderna</li>
</ul>
</td>
</tr>
</tbody>
</table>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 6</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the methods of local anesthetic administration with their descriptions.</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 70.8989%;" width="501">
<p><strong>Column-A </strong></p>
</td>
<td style="width: 29.1011%;" width="197">
<p><strong>Column-B </strong></p>
</td>
</tr>
<tr>
<td style="width: 70.8989%;" width="501">
<p>A.&nbsp;&nbsp; Injection of agent into subarachnoid space</p>
<p>B.&nbsp;&nbsp;&nbsp; Injection of anesthetic agent directly into tissues</p>
<p>C.&nbsp;&nbsp;&nbsp; Injection of a specific nerve with an anesthetic agent</p>
<p>D.&nbsp;&nbsp; Injection of anesthetic agent into space around the vertebrae</p>
<p>E.&nbsp;&nbsp;&nbsp; Injection of agent into veins of extremity after limb is exsanguinated</p>
</td>
<td style="width: 29.1011%;" width="197">
<p>1)&nbsp;&nbsp;&nbsp; Nerve block</p>
<p>2)&nbsp;&nbsp;&nbsp; IV nerve block</p>
<p>3)&nbsp;&nbsp;&nbsp; Spinal block</p>
<p>4)&nbsp;&nbsp;&nbsp; Epidural block</p>
<p>5)&nbsp;&nbsp;&nbsp; Local infiltration</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-3, B-5, C-1, D-4, E-2</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-3, B-4, C-5, D-1, E-2</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-5, B-3, C-1, D-4, E-2</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-4, B-5, C-1, D-3, E-2</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li><strong>Injection into the subarachnoid space</strong>: This describes a <strong>spinal block</strong>, where the anesthetic is injected into the cerebrospinal fluid in the subarachnoid space, providing profound anesthesia for surgeries involving the lower abdomen, pelvis, or lower limbs.</li>
<li><strong>Injection directly into tissues</strong>: This method is known as <strong>local infiltration</strong>, commonly used for minor procedures to numb a specific area by injecting anesthetic into the surrounding tissues.</li>
<li><strong>Injection into a specific nerve</strong>: This is a <strong>nerve block</strong>, where the anesthetic is administered near a specific nerve or nerve group to block sensation in the area supplied by the nerve.</li>
<li><strong>Injection into space around the vertebrae</strong>: This refers to an <strong>epidural block</strong>, where the anesthetic is delivered into the epidural space outside the dura mater to provide anesthesia or pain relief, commonly used in labor and surgeries.</li>
<li><strong>Injection into veins after limb exsanguination</strong>: This is an <strong>IV nerve block</strong> (also called a Bier block), used for surgeries on extremities. The limb is exsanguinated (drained of blood) using a tourniquet, and anesthetic is injected into the veins to provide regional anesthesia.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 7</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the following Amino acids and their respective derivatives.</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 50%;" width="236">
<p><strong>Column-A</strong></p>
</td>
<td style="width: 50%;" width="236">
<p><strong>Column-B</strong></p>
</td>
</tr>
<tr>
<td style="width: 50%;" width="236">
<p>1)&nbsp;&nbsp;&nbsp; Histidine</p>
<p>2)&nbsp;&nbsp;&nbsp; Tryptophan</p>
<p>3)&nbsp;&nbsp;&nbsp; Tyrosine</p>
<p>4)&nbsp;&nbsp;&nbsp; Cysteine &nbsp;</p>
</td>
<td style="width: 50%;" width="236">
<p>A.&nbsp;&nbsp; Catecholamine</p>
<p>B.&nbsp;&nbsp;&nbsp; Glutathione</p>
<p>C.&nbsp;&nbsp;&nbsp; Histamine</p>
<p>D.&nbsp;&nbsp; Melatonin</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>&nbsp;1-C, 2-D, 3-A, 4-B</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-C, 2-B, 3-A, 4-D</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-D, 2-C, 3-A, 4-B</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-B, 2-D, 3-A, 4-D</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>End products of amino acid metabolism </strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 38.764%;" width="279">
<p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amino acid </strong></p>
</td>
<td style="width: 61.236%;" width="449">
<p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; End products</strong></p>
</td>
</tr>
<tr>
<td style="width: 38.764%;" width="279">
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Glycine </strong></p>
<p>&nbsp;</p>
</td>
<td style="width: 61.236%;" width="449">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Serine, Cysteine, Choline</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Heme synthesis</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Glutathione formation</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bile salt</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Creatinine formation</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C4, C5, N7 of purine ring</p>
</td>
</tr>
<tr>
<td style="width: 38.764%;" width="279">
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>&nbsp;Serine </strong></p>
<p>&nbsp;</p>
</td>
<td style="width: 61.236%;" width="449">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Formation of Sphingosine, Cysteine, Selenocysteine</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Formation of choline and acetylcholine</p>
</td>
</tr>
<tr>
<td style="width: 38.764%;" width="279">
<p><strong>Methionine and Cysteine </strong></p>
<p>&nbsp;</p>
</td>
<td style="width: 61.236%;" width="449">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Formation of pyruvate, CoA</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Taurine and Glutathione formation</p>
</td>
</tr>
<tr>
<td style="width: 38.764%;" width="279">
<p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Arginine </strong></p>
<p>&nbsp;</p>
</td>
<td style="width: 61.236%;" width="449">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Urea, Creatinine</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Formation of Nitric oxide</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Agmatine</p>
</td>
</tr>
<tr>
<td style="width: 38.764%;" width="279">
<p><strong>&nbsp;</strong></p>
<p><strong>Phenylalanine and Tyrosine</strong></p>
<p>&nbsp;</p>
</td>
<td style="width: 61.236%;" width="449">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; T3 and T4 formation</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Production of melanin, Epinephrine, Norepinephrine, DOPA, Dopamine</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tyramine</p>
</td>
</tr>
<tr>
<td style="width: 38.764%;" width="279">
<p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tryptophan </strong></p>
</td>
<td style="width: 61.236%;" width="449">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Serotonin, Melatonin, Niacin</p>
</td>
</tr>
<tr>
<td style="width: 38.764%;" width="279">
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Glutamic acid </strong></p>
</td>
<td style="width: 61.236%;" width="449">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GABA and Glutathione formation</p>
</td>
</tr>
</tbody>
</table>
<p><strong>Amino acid Derivatives</strong></p>
<p><img title="image007.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/138de447-9360-4264-9c7c-fa7be5bf3703.png" alt="" width="475" height="403" /></p>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 8</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the following vaccines with their respective route of administration:</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 50%;" width="208">
<p><strong>Vaccine</strong></p>
</td>
<td style="width: 50%;" width="208">
<p><strong>Route</strong></p>
</td>
</tr>
<tr>
<td style="width: 50%;" width="208">
<p>1. Pneumococcal conjugate</p>
</td>
<td style="width: 50%;" width="208">
<p>A. Oral</p>
</td>
</tr>
<tr>
<td style="width: 50%;" width="208">
<p>2. BCG</p>
</td>
<td style="width: 50%;" width="208">
<p>B. Subcutaneous</p>
</td>
</tr>
<tr>
<td style="width: 50%;" width="208">
<p>3. JE</p>
</td>
<td style="width: 50%;" width="208">
<p>C. Intradermal</p>
</td>
</tr>
<tr>
<td style="width: 50%;" width="208">
<p>4. Rotavirus</p>
</td>
<td style="width: 50%;" width="208">
<p>D. Intramuscular</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-D, 2-B, 3-C, 4-A</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-C, 2-A, 3-D, 4-B</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-C, 2-B, 3-D, 4-A</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-D, 2-C, 3-B, 4-A</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>The correct option is <strong>1-D, 2-C, 3-B, 4-A.</strong></p>
<ul>
<li><strong>BCG</strong> is intradermally administered.</li>
<li>Hepatitis B vaccine, Pentavalent vaccine, along with DPT, <strong>Pneumococcal conjugate Vaccine</strong>, and the tetanus toxoid are administered via the <strong>intramuscular route.</strong></li>
<li>OPV and <strong>Rotaviral vaccines</strong> are administered</li>
<li>The vaccines that are administered <strong>subcutaneously</strong> are Measles/Rubella vaccine and the <strong>JE vaccine. </strong></li>
</ul>
<p><strong>National immunization schedule </strong></p>
<p><strong>For Pregnant Women</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 16.6344%;" width="96">
<p><strong>Vaccine</strong></p>
</td>
<td style="width: 29.5938%;" width="234">
<p><strong>When to give</strong></p>
</td>
<td style="width: 13.5397%;" width="84">
<p><strong>Dose</strong></p>
</td>
<td style="width: 21.2766%;" width="144">
<p><strong>Route </strong></p>
</td>
<td style="width: 18.9555%;" width="144">
<p><strong>Site </strong></p>
</td>
</tr>
<tr>
<td style="width: 16.6344%;" width="96">
<p>Td-1</p>
</td>
<td style="width: 29.5938%;" width="234">
<p>Early in pregnancy</p>
</td>
<td style="width: 13.5397%;" width="84">
<p>0.5 mL</p>
</td>
<td style="width: 21.2766%;" width="144">
<p>Intra-muscular</p>
</td>
<td style="width: 18.9555%;" width="144">
<p>Upper arm</p>
</td>
</tr>
<tr>
<td style="width: 16.6344%;" width="96">
<p>Td-2</p>
</td>
<td style="width: 29.5938%;" width="234">
<p>4 weeks after Td-1*</p>
</td>
<td style="width: 13.5397%;" width="84">
<p>0.5 mL</p>
</td>
<td style="width: 21.2766%;" width="144">
<p>Intra-muscular</p>
</td>
<td style="width: 18.9555%;" width="144">
<p>Upper arm</p>
</td>
</tr>
<tr>
<td style="width: 16.6344%;" width="96">
<p>Td- Booster</p>
</td>
<td style="width: 29.5938%;" width="234">
<p>If received 2 Td doses in a pregnancy within the last 3 years*</p>
</td>
<td style="width: 13.5397%;" width="84">
<p>0.5 mL</p>
</td>
<td style="width: 21.2766%;" width="144">
<p>Intra-muscular</p>
</td>
<td style="width: 18.9555%;" width="144">
<p>Upper arm</p>
</td>
</tr>
</tbody>
</table>
<p><strong>For Infants </strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 21.2766%;" width="144">
<p><strong>Vaccine</strong></p>
</td>
<td style="width: 19.3424%;" width="144">
<p><strong>When to give</strong></p>
</td>
<td style="width: 14.7002%;" width="144">
<p><strong>Dose</strong></p>
</td>
<td style="width: 22.824%;" width="144">
<p><strong>Route </strong></p>
</td>
<td style="width: 22.0503%;" width="144">
<p><strong>Site </strong></p>
</td>
</tr>
<tr>
<td style="width: 21.2766%;" width="144">
<p>BCG</p>
</td>
<td style="width: 19.3424%;" width="144">
<p>At birth or as early as possible until &nbsp;one year of age &nbsp;</p>
</td>
<td style="width: 14.7002%;" width="144">
<p>0.1 mL (0.05 mL until 1 month age)</p>
</td>
<td style="width: 22.824%;" width="144">
<p>Intra-dermal</p>
</td>
<td style="width: 22.0503%;" width="144">
<p>Left upper arm</p>
</td>
</tr>
<tr>
<td style="width: 21.2766%;" width="144">
<p>Hepatitis B - Birth Dose</p>
</td>
<td style="width: 19.3424%;" width="144">
<p>At birth or as early as possible within 24 hours &nbsp;</p>
</td>
<td style="width: 14.7002%;" width="144">
<p>0.5 mL</p>
</td>
<td style="width: 22.824%;" width="144">
<p>Intra-muscular</p>
</td>
<td style="width: 22.0503%;" width="144">
<p>Antero-lateral side of mid-thigh</p>
</td>
</tr>
<tr>
<td style="width: 21.2766%;" width="144">
<p>OPV - 0</p>
</td>
<td style="width: 19.3424%;" width="144">
<p>At birth or as early as &nbsp;possible within the first 15 days</p>
</td>
<td style="width: 14.7002%;" width="144">
<p>2 drops</p>
</td>
<td style="width: 22.824%;" width="144">
<p>Oral</p>
</td>
<td style="width: 22.0503%;" width="144">
<p>Oral</p>
</td>
</tr>
<tr>
<td style="width: 21.2766%;" width="144">
<p>OPV-1, 2 and 3</p>
</td>
<td style="width: 19.3424%;" width="144">
<p>At 6 weeks, 10 weeks, and 14 weeks (can be given until 5 years of age)</p>
</td>
<td style="width: 14.7002%;" width="144">
<p>2 drops</p>
</td>
<td style="width: 22.824%;" width="144">
<p>Oral</p>
</td>
<td style="width: 22.0503%;" width="144">
<p>Oral</p>
</td>
</tr>
<tr>
<td style="width: 21.2766%;" width="144">
<p>Pentavalent 1. 2 and 3</p>
</td>
<td style="width: 19.3424%;" width="144">
<p>At 6 weeks, 10 weeks, and 14 weeks (can be given until one year of age)</p>
</td>
<td style="width: 14.7002%;" width="144">
<p>0.5 mL</p>
</td>
<td style="width: 22.824%;" width="144">
<p>Intra-muscular</p>
</td>
<td style="width: 22.0503%;" width="144">
<p>Antero-lateral side of mid-thigh</p>
</td>
</tr>
<tr>
<td style="width: 21.2766%;" width="144">
<p>Rotavirus</p>
</td>
<td style="width: 19.3424%;" width="144">
<p>At 6 weeks, 10 weeks, and 14 weeks (can be given until one year of age)</p>
</td>
<td style="width: 14.7002%;" width="144">
<p>5 drops</p>
</td>
<td style="width: 22.824%;" width="144">
<p>Oral</p>
</td>
<td style="width: 22.0503%;" width="144">
<p>Oral</p>
</td>
</tr>
<tr>
<td style="width: 21.2766%;" width="144">
<p>IPV</p>
</td>
<td style="width: 19.3424%;" width="144">
<p>Three fractional doses at 6, 14 weeks and 9 months of age</p>
</td>
<td style="width: 14.7002%;" width="144">
<p>0.1 mL</p>
</td>
<td style="width: 22.824%;" width="144">
<p>Intra-dermal 3 fractional dose</p>
</td>
<td style="width: 22.0503%;" width="144">
<p>Intra-dermal: right Upper arm (at 6, 14 weeks); left upper arm (at 9 months)</p>
</td>
</tr>
<tr>
<td style="width: 21.2766%;" width="144">
<p>PCV (wherever applicable)</p>
</td>
<td style="width: 19.3424%;" width="144">
<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>
</td>
<td style="width: 14.7002%;" width="144">
<p>0.5 mL</p>
</td>
<td style="width: 22.824%;" width="144">
<p>Intra-muscular</p>
</td>
<td style="width: 22.0503%;" width="144">
<p>Antero-lateral side of mid-thigh, right</p>
</td>
</tr>
<tr>
<td style="width: 21.2766%;" width="144">
<p>Measles/MR 1<sup>st</sup> &nbsp;Dose</p>
</td>
<td style="width: 19.3424%;" width="144">
<p>9 completed months to 12 months (Can be given till 5 years of age)</p>
</td>
<td style="width: 14.7002%;" width="144">
<p>0.5 mL</p>
</td>
<td style="width: 22.824%;" width="144">
<p>Sub-cutaneous</p>
</td>
<td style="width: 22.0503%;" width="144">
<p>Right upper arm</p>
</td>
</tr>
<tr>
<td style="width: 21.2766%;" width="144">
<p>JE- 1**</p>
</td>
<td style="width: 19.3424%;" width="144">
<p>9 completed months to 12 months</p>
</td>
<td style="width: 14.7002%;" width="144">
<p>0.5 mL</p>
</td>
<td style="width: 22.824%;" width="144">
<p>Sub-cutaneous (Live attenuated) Intramuscular (Killed vaccine)</p>
</td>
<td style="width: 22.0503%;" width="144">
<p>Left upper arm (Live attenuated)</p>
<p>&nbsp;</p>
<p>Anterolateral aspect of mid- thigh (Killed vaccine)</p>
</td>
</tr>
<tr>
<td style="width: 21.2766%;" width="144">
<p>Vitamin A (1<sup>st</sup> dose)</p>
</td>
<td style="width: 19.3424%;" width="144">
<p>At 9 completed months with measles &nbsp;Rubella</p>
</td>
<td style="width: 14.7002%;" width="144">
<p>1 mL (1 lakh IU)</p>
</td>
<td style="width: 22.824%;" width="144">
<p>Oral</p>
</td>
<td style="width: 22.0503%;" width="144">
<p>Oral</p>
</td>
</tr>
</tbody>
</table>
<p><strong>For Children </strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 20.3095%;" width="144">
<p><strong>Vaccine</strong></p>
</td>
<td style="width: 20.3095%;" width="144">
<p><strong>When to give</strong></p>
</td>
<td style="width: 17.795%;" width="144">
<p><strong>Dose</strong></p>
</td>
<td style="width: 21.8569%;" width="144">
<p><strong>Route </strong></p>
</td>
<td style="width: 19.5358%;" width="144">
<p><strong>Site </strong></p>
</td>
</tr>
<tr>
<td style="width: 20.3095%;" width="144">
<p>DPT booster-1</p>
</td>
<td style="width: 20.3095%;" width="144">
<p>16-24 months</p>
</td>
<td style="width: 17.795%;" width="144">
<p>0.5 mL</p>
</td>
<td style="width: 21.8569%;" width="144">
<p>Intra-muscular</p>
</td>
<td style="width: 19.5358%;" width="144">
<p>Antero-lateral side of mid-thigh</p>
</td>
</tr>
<tr>
<td style="width: 20.3095%;" width="144">
<p>Measles / MR 2<sup>nd</sup> dose</p>
</td>
<td style="width: 20.3095%;" width="144">
<p>16-24 months</p>
</td>
<td style="width: 17.795%;" width="144">
<p>0.5 mL</p>
</td>
<td style="width: 21.8569%;" width="144">
<p>Sub-cutaneous</p>
</td>
<td style="width: 19.5358%;" width="144">
<p>Right upper arm</p>
</td>
</tr>
<tr>
<td style="width: 20.3095%;" width="144">
<p>OPV booster</p>
</td>
<td style="width: 20.3095%;" width="144">
<p>16-24 months</p>
</td>
<td style="width: 17.795%;" width="144">
<p>2 drops</p>
</td>
<td style="width: 21.8569%;" width="144">
<p>Oral</p>
</td>
<td style="width: 19.5358%;" width="144">
<p>Oral</p>
</td>
</tr>
<tr>
<td style="width: 20.3095%;" width="144">
<p>JE-2</p>
</td>
<td style="width: 20.3095%;" width="144">
<p>16-24 months</p>
</td>
<td style="width: 17.795%;" width="144">
<p>0.5 mL</p>
</td>
<td style="width: 21.8569%;" width="144">
<p>Sub-cutaneous</p>
</td>
<td style="width: 19.5358%;" width="144">
<p>Left upper arm</p>
</td>
</tr>
<tr>
<td style="width: 20.3095%;" width="144">
<p>Vitamin A*** (2<sup>nd</sup> to 9<sup>th</sup> dose)</p>
</td>
<td style="width: 20.3095%;" width="144">
<p>16-18 months, followed by one dose every 6 months up to the age of 5 years</p>
</td>
<td style="width: 17.795%;" width="144">
<p>2 mL (2 lakh IU)</p>
</td>
<td style="width: 21.8569%;" width="144">
<p>Oral</p>
</td>
<td style="width: 19.5358%;" width="144">
<p>Oral</p>
</td>
</tr>
<tr>
<td style="width: 20.3095%;" width="144">
<p>DPT booster 2</p>
</td>
<td style="width: 20.3095%;" width="144">
<p>5-6 years</p>
</td>
<td style="width: 17.795%;" width="144">
<p>0.5 mL</p>
</td>
<td style="width: 21.8569%;" width="144">
<p>Intra-muscular</p>
</td>
<td style="width: 19.5358%;" width="144">
<p>Upper arm</p>
</td>
</tr>
<tr>
<td style="width: 20.3095%;" width="144">
<p>Td</p>
</td>
<td style="width: 20.3095%;" width="144">
<p>10 ears and 16 years</p>
</td>
<td style="width: 17.795%;" width="144">
<p>0.5 mL</p>
</td>
<td style="width: 21.8569%;" width="144">
<p>Intra-muscular</p>
</td>
<td style="width: 19.5358%;" width="144">
<p>Upper arm</p>
</td>
</tr>
</tbody>
</table>
<p><strong>*</strong>Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>
<p><strong>**</strong>JE vaccine is introduced in select endemic districts after the campaigns.</p>
<p>** Killed Inactivated JE vaccine</p>
<p>***The 2<sup>nd</sup> to 9<sup>th</sup> doses of vitamin A can be administered to children 1-5 years old during biannual rounds, in collaboration with ICDS.</p>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 9</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the Causative organism with their respective disease.</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 50.0967%;" width="265">
<p><strong>Causative organism</strong></p>
</td>
<td style="width: 49.9033%;" width="265">
<p><strong>Disease</strong></p>
</td>
</tr>
<tr>
<td style="width: 50.0967%;" width="265">
<p>A.&nbsp;&nbsp; Klebsiella granulomatous</p>
<p>B.&nbsp;&nbsp;&nbsp; Bartonella bacilliformis</p>
<p>C.&nbsp;&nbsp;&nbsp; Treponema carateum</p>
<p>D.&nbsp;&nbsp; Streptobacillus monoliformis</p>
</td>
<td style="width: 49.9033%;" width="265">
<p>1)&nbsp;&nbsp;&nbsp; Rat bite fever</p>
<p>2)&nbsp;&nbsp;&nbsp; Donovanosis</p>
<p>3)&nbsp;&nbsp;&nbsp; Oroya fever</p>
<p>4)&nbsp;&nbsp;&nbsp; Pinta</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-3, B-2, C-4, D-3</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-2, B-3, C-4, D-1</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-2, B-3, C-1, D-4</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-4, B-1, C-2, D-3</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Klebsiella granulomatous</strong></p>
<ul>
<li>Earlier called as Calymmatobacterium granulomatis.</li>
<li>Gram-negative rod, safety pin appearance.</li>
<li>It causes veneral disease named as <strong><em>donovanosis or granuloma Inguinale.</em></strong></li>
<li><strong>Lab diagnosis:</strong> Demonstration of <strong>donovan bodies</strong> in Giemsa stain from lesion in the genital area.</li>
<li>DOC: Tetracycline</li>
</ul>
<p><strong>Bartonella bacilliformis</strong></p>
<ul>
<li>Bartonella bacilliformis is the only species in the Bartonella genus that invades erythrocytes.</li>
<li><strong><em>Bartonella bacilliformis</em></strong> is a Gram-negative facultative intracellular bacterium that causes <strong>Carrion's disease</strong>, a biphasic illness endemic to certain regions of South America, particularly in high-altitude areas of Peru, Colombia, and Ecuador.</li>
<li>Spread by sandflies (Lutzomyia spp.).</li>
<li><strong>Causes:</strong></li>
</ul>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 49.9033%;" width="320">
<p><strong>Acute Phase (Oroya Fever)</strong></p>
</td>
<td style="width: 50.0967%;" width="341">
<p><strong>Chronic Phase (Verruga Peruana)</strong></p>
</td>
</tr>
<tr>
<td style="width: 49.9033%;" width="320">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; High fever, malaise, severe headache, muscle pain, and abdominal pain.</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute <strong>hemolytic anemia</strong> due to massive invasion of erythrocytes by the bacteria.</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Treatment:</strong> <strong>ciprofloxacin</strong>, <strong>chloramphenicol</strong>, or <strong>ceftriaxone</strong>.</p>
</td>
<td style="width: 50.0967%;" width="341">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Characterized by <strong>vascular skin lesions</strong> that appear as nodules, papules, or miliary lesions (commonly referred to as Peruvian warts).</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lesions are highly vascularized and may bleed easily.</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Treatment: Azithromycin</strong> or <strong>rifampin</strong> is effective for treating skin lesions.</p>
</td>
</tr>
</tbody>
</table>
<p><strong>Treponema carateum</strong></p>
<ul>
<li>The causative agent for <strong>Pinta</strong> (carate, mal del pinto) is <strong><em>Treponema carateum.</em></strong></li>
<li>The primary lesion is a papule which does not ulcerate but develops into lichenoid or psoriaform patch.</li>
<li>It affects only skin. Secondary skin lesions are characterized by hypo or hyperpigmentation.</li>
</ul>
<p><strong>Pathogenic Spirochaetes </strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 53.3849%;" width="283">
<p><strong>Organisms</strong></p>
</td>
<td style="width: 46.6151%;" width="247">
<p><strong>Disease Caused</strong></p>
</td>
</tr>
<tr>
<td style="width: 53.3849%;" width="283">
<p>Treponema pallidum (Veneral)</p>
</td>
<td style="width: 46.6151%;" width="247">
<p>Syphilis</p>
</td>
</tr>
<tr>
<td style="width: 53.3849%;" width="283">
<p>Treponema endemicum&nbsp; (Non-veneral)</p>
</td>
<td style="width: 46.6151%;" width="247">
<p>Bejel</p>
</td>
</tr>
<tr>
<td style="width: 53.3849%;" width="283">
<p>Treponema pertunae (Non-veneral)</p>
</td>
<td style="width: 46.6151%;" width="247">
<p>Yaws</p>
</td>
</tr>
<tr>
<td style="width: 53.3849%;" width="283">
<p>Treponema carateum (Non-veneral)</p>
</td>
<td style="width: 46.6151%;" width="247">
<p>Pinta</p>
</td>
</tr>
<tr>
<td style="width: 53.3849%;" width="283">
<p>Borrelia burgdorferi</p>
</td>
<td style="width: 46.6151%;" width="247">
<p>Lyme's disease</p>
</td>
</tr>
<tr>
<td style="width: 53.3849%;" width="283">
<p>Borrelia recurrentis</p>
</td>
<td style="width: 46.6151%;" width="247">
<p>Relapsing fever</p>
</td>
</tr>
<tr>
<td style="width: 53.3849%;" width="283">
<p>Borrelia vincenti</p>
</td>
<td style="width: 46.6151%;" width="247">
<p>Vincent angina</p>
</td>
</tr>
<tr>
<td style="width: 53.3849%;" width="283">
<p>Leptospira interrogans</p>
</td>
<td style="width: 46.6151%;" width="247">
<p>Weil's disease</p>
</td>
</tr>
</tbody>
</table>
<p><strong>Streptobacillus</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 52.0309%;" width="349">
<p><strong>Streptobacillary rat bite fever </strong></p>
</td>
<td style="width: 47.9691%;" width="349">
<p><strong>Spirillary rat bite fever </strong></p>
</td>
</tr>
<tr>
<td style="width: 52.0309%;" width="349">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Causative agent: <strong><em>Streptobacillus monoliformis</em></strong></p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Also called as Haverhill fever</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gram negative, higly pleomorphic, no-motile</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cultivable by artificial media</p>
</td>
<td style="width: 47.9691%;" width="349">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Causative agent: <em>Spirillum minus</em></p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Called as Sudoku</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gram negative, spirally coiled, motile</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-Cultivable</p>
</td>
</tr>
</tbody>
</table>
<p><strong>Quick Revision</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 48.9362%;" width="334">
<p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever</strong></p>
</td>
<td style="width: 51.0638%;" width="350">
<p><strong>Organism</strong></p>
</td>
</tr>
<tr>
<td style="width: 48.9362%;" width="334">
<p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shanghai fever </strong></p>
</td>
<td style="width: 51.0638%;" width="350">
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pseudomonas</p>
</td>
</tr>
<tr>
<td style="width: 48.9362%;" width="334">
<p><strong>&nbsp;&nbsp;&nbsp; Undulant/ Malta fever</strong></p>
</td>
<td style="width: 51.0638%;" width="350">
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brucella</p>
</td>
</tr>
<tr>
<td style="width: 48.9362%;" width="334">
<p><strong>&nbsp;&nbsp; Brazilian purpuric fever</strong></p>
</td>
<td style="width: 51.0638%;" width="350">
<p>&nbsp; Haemophilus aegyptius</p>
</td>
</tr>
<tr>
<td style="width: 48.9362%;" width="334">
<p><strong>&nbsp; Haverhill/Rat bite fever</strong></p>
</td>
<td style="width: 51.0638%;" width="350">
<p>&nbsp; Streptobacillus moniliformis</p>
</td>
</tr>
<tr>
<td style="width: 48.9362%;" width="334">
<p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Soduku</strong></p>
</td>
<td style="width: 51.0638%;" width="350">
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Spirillum minus</p>
</td>
</tr>
<tr>
<td style="width: 48.9362%;" width="334">
<p><strong>&nbsp;&nbsp;&nbsp;&nbsp; Cat scratch disease</strong></p>
</td>
<td style="width: 51.0638%;" width="350">
<p>&nbsp;&nbsp;&nbsp; Bartonella hensele</p>
</td>
</tr>
<tr>
<td style="width: 48.9362%;" width="334">
<p><strong>&nbsp;Oraya fever/ Carrion&rsquo;s disease</strong></p>
</td>
<td style="width: 51.0638%;" width="350">
<p>&nbsp;&nbsp; Bartonella bcilliformis</p>
</td>
</tr>
<tr>
<td style="width: 48.9362%;" width="334">
<p><strong>&nbsp; Goal fever/ Epidemic thypus</strong></p>
</td>
<td style="width: 51.0638%;" width="350">
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; R. prowazekii</p>
</td>
</tr>
<tr>
<td style="width: 48.9362%;" width="334">
<p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Weil&rsquo;s disease</strong></p>
</td>
<td style="width: 51.0638%;" width="350">
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Leptospira</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 10</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the following drugs with the condition they are used?</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 48.7427%;" width="255">
<p><strong>Condition</strong></p>
</td>
<td style="width: 51.2573%;" width="274">
<p><strong>Drugs</strong></p>
</td>
</tr>
<tr>
<td style="width: 48.7427%;" width="255">
<p>A.&nbsp;&nbsp; Alcohol dependence</p>
<p>B.&nbsp;&nbsp;&nbsp; Benzodiazepines overdose</p>
<p>C.&nbsp;&nbsp;&nbsp; Smoking cessation</p>
<p>D.&nbsp;&nbsp; Delirium tremens</p>
</td>
<td style="width: 51.2573%;" width="274">
<p>1)&nbsp;&nbsp;&nbsp; Flumazenil</p>
<p>2)&nbsp;&nbsp;&nbsp; Acamprosate</p>
<p>3)&nbsp;&nbsp;&nbsp; Oxazepam</p>
<p>4)&nbsp;&nbsp;&nbsp; Varenicline</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-2, B-1, C-4, D-3</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-2, B-3, C-4, D-1</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-1, B-3, C-2, D-4</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-4, B-1, C-3, D-2</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Alcohol dependence- Acamprosate</strong></p>
<ul>
<li><strong>Acamprosate:</strong> An NMDA receptor antagonist with modest GABA A receptor agonistic activity; useful in maintaining abstinence and decreasing cravings of alcohol.</li>
<li>Should be started post-detoxification for relapse prevention in patients who have stopped drinking.</li>
</ul>
<p><strong>Anti-craving drugs used in alcohol deaddiction include: </strong></p>
<ul>
<li>Baclofen</li>
<li>Acamprosate</li>
<li>Naltrexone- It is an orally active opioid antagonist.</li>
<li>Newer drugs are topiramate, SSRI and ondansetron.</li>
</ul>
<p><strong>Deterrent agent: </strong></p>
<ul>
<li><strong>Disulfiram</strong> is a <strong>deterrent agent,</strong> not an anti-craving drug. It is an irreversible <strong>aldehyde dehydrogenase inhibitor</strong>.</li>
<li>Acetaldehyde is the first breakdown product of alcohol, which is further metabolized by aldehyde dehydrogenase. If a patient who is on disulfiram consumes alcohol, it results in toxic levels of acetaldehyde.</li>
<li>This causes symptoms such as flushing, pulsating headache, nausea, vomiting, respiratory difficulties, chest pain, and autonomic manifestations, collectively termed as <strong>Disulfiram ethanol reaction</strong> (DER).</li>
<li>Other deterrent agents include citrated <strong>calcium carbamide</strong> and</li>
</ul>
<p><strong>Benzodiazepines Overdose-Flumazenil</strong></p>
<ul>
<li>Flumazenil is a specific and exclusive benzodiazepine antagonist. It presents and reverses in a dose dependent names all the agonist effects of benzodiazepine.</li>
<li>Flumazenil is the first benzodiazepine antagonist approved for clinical use to reverse the effects of benzodiazepines. It is a competitive antagonist at the benzodiazepine receptor and produces antagonism that is reversible.</li>
<li>Flumazenil is a very short-acting Benzodiazepines antagonist used for treating Benzodiazepines overdose. Use with caution when treating overdose, as it can cause seizures/status epilepticus in chronic benzodiazepine users.</li>
<li>Other antidote for Benzodiazepines toxicity: Consider decontamination (activated charcoal).</li>
<li>Flumazenil antidote contraindicated in combined TCA and benzodiazepine overdose.</li>
<li>It is a benzodiazepine receptor ligand which has a high affinity and specificity.</li>
<li>Flumazenil is used for both diagnostic and therapeutic reversal of benzodiazepine receptor agonists.</li>
<li><strong>Dosing Schedule:</strong>3 mg IV bolus q5 min x 3 doses</li>
</ul>
<p><strong>Smoking cessation- Varenicline </strong></p>
<ul>
<li>It is a pharmacotherapy for Smoking Cessation.</li>
<li><strong>&alpha;<sub>4</sub>&beta;<sub>4 </sub>-partial nicotinic Ach receptor agonist</strong>- (to reduce cravings) and partial competitive nicotinic receptor antagonist (to reduce the response to smoked nicotine).</li>
<li>More effective than bupropion.</li>
<li>Significant side effects may lower patient compliance.</li>
<li><strong>Doses:</strong>
<ul>
<li>5 mg qAM x 3 d</li>
<li>Then 0.5 mg bid x 4 d</li>
<li>Continue 1 mg bid x 12 week &plusmn; additional 12 weeks as maintenance</li>
</ul>
</li>
</ul>
<p><strong>Delirium tremens- Oxazepam</strong></p>
<ul>
<li>Oxazepam used for the treatment of alcohol withdrawal symptoms and sedative-hypnotic-anxiolytic detoxification. It is not metabolized by liver.</li>
<li>The <strong>best treatment</strong> for delirium tremens is prevention. Patients withdrawing from alcohol <strong>who exhibit withdrawal phenomena</strong> should receive <strong>benzodiazepines,</strong> such as 25 to 50 mg of chlordiazepoxide every 2 to 4 hours until they seem to be out of danger.</li>
<li><strong>Chlordiazepoxide </strong>is a benzodiazepine drug used in <strong>alcohol withdrawal</strong> and the <strong>detoxification</strong> phase of management.</li>
<li>Once the delirium appears, 50 to 100 mg of <strong>chlordiazepoxide </strong>should be given every 4 hours orally, or <strong>lorazepam </strong>should be given intravenously (IV) if oral medication is not possible.</li>
<li>A <strong>high-calorie, high-carbohydrate diet</strong> supplemented by multivitamins is also important. Carbohydrates increase the serotonin levels similar to alcohol, lowering the rates of withdrawal seizures.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 11</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the following specialized macrophages with the tissues they are found in.</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 46.8539%;" width="265">
<p><strong>Cell</strong></p>
</td>
<td style="width: 53.1461%;" width="302">
<p><strong>Tissue</strong></p>
</td>
</tr>
<tr>
<td style="width: 46.8539%;" width="265">
<p>I. Hofbauer cells</p>
<p>II. Histiocytes</p>
<p>III. Kupffer cells</p>
<p>V. Microglia</p>
<p>V. Mesangial cells</p>
</td>
<td style="width: 53.1461%;" width="302">
<p>A.&nbsp;&nbsp; Kidney</p>
<p>B.&nbsp;&nbsp;&nbsp; Placenta</p>
<p>C.&nbsp;&nbsp;&nbsp; Connective tissue</p>
<p>D.&nbsp;&nbsp; Liver</p>
<p>E.&nbsp;&nbsp;&nbsp; Brain</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>I-A; II-C; III-D; IV-E; V-B</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>I-C; II-B; III-D; IV-E; V-A</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>I-D; II-C; III-A; IV-B; V-E</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>I-B; II-C; III-D; IV-E; V-A</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 44.4944%;" width="217">
<p><strong>Site</strong></p>
</td>
<td style="width: 55.5056%;" width="274">
<p><strong>Macrophage designation</strong></p>
</td>
</tr>
<tr>
<td style="width: 44.4944%;" width="217">
<p>Peripheral blood</p>
</td>
<td style="width: 55.5056%;" width="274">
<p>Monocytes</p>
</td>
</tr>
<tr>
<td style="width: 44.4944%;" width="217">
<p>Placenta</p>
</td>
<td style="width: 55.5056%;" width="274">
<p>Hofbauer cells</p>
</td>
</tr>
<tr>
<td style="width: 44.4944%;" width="217">
<p>Liver</p>
</td>
<td style="width: 55.5056%;" width="274">
<p>Kupffer cells</p>
</td>
</tr>
<tr>
<td style="width: 44.4944%;" width="217">
<p>Brain</p>
</td>
<td style="width: 55.5056%;" width="274">
<p>Microglial cells</p>
</td>
</tr>
<tr>
<td style="width: 44.4944%;" width="217">
<p>Kidney</p>
</td>
<td style="width: 55.5056%;" width="274">
<p>Mesangial cells</p>
</td>
</tr>
<tr>
<td style="width: 44.4944%;" width="217">
<p>Lungs</p>
</td>
<td style="width: 55.5056%;" width="274">
<p>Alveolar macrophages</p>
</td>
</tr>
<tr>
<td style="width: 44.4944%;" width="217">
<p>Bone</p>
</td>
<td style="width: 55.5056%;" width="274">
<p>Osteoclasts</p>
</td>
</tr>
<tr>
<td style="width: 44.4944%;" width="217">
<p>Connective tissue</p>
</td>
<td style="width: 55.5056%;" width="274">
<p>Histiocytes</p>
</td>
</tr>
</tbody>
</table>
<p><strong>Macrophage</strong>s can be divided into:</p>
<ul>
<li><strong>Blood macrophages</strong> (monocytes) are the largest of the myeloid cells in the peripheral blood. Life span: 3 days.</li>
<li><strong>Tissue macrophages</strong> survive for months.</li>
</ul>
<p>The <strong>main functions</strong> of macrophages are phagocytosis and antigen presentation.</p>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 12</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the following.</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 50%;" width="349">
<p><strong>Biological indicators of efficiency</strong></p>
</td>
<td style="width: 50%;" width="349">
<p><strong>Sterilization methods</strong></p>
</td>
</tr>
<tr>
<td style="width: 50%;" width="349">
<p><em>a)&nbsp;&nbsp;&nbsp; </em><em>Clostridium tetani</em></p>
<p><em>b)&nbsp;&nbsp;&nbsp; </em><em>Geobacillus stearothermophilus</em></p>
<p><em>c)&nbsp;&nbsp;&nbsp;&nbsp; </em><em>Bacillus atrophaeus</em></p>
<p>d)&nbsp;&nbsp;&nbsp; <em>Bacillus pumilus</em></p>
</td>
<td style="width: 50%;" width="349">
<p>a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ethylene oxide</p>
<p>b.&nbsp;&nbsp;&nbsp;&nbsp; Ionizing radiation</p>
<p>c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Autoclave</p>
<p>d.&nbsp;&nbsp;&nbsp;&nbsp; Hot air oven</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-a, 2-b, 3-d, 4-c</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-d, 2-c, 3-a, 4-b &nbsp;</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-c, 2-d, 3-b, 4-a</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-b, 2-a, 3-c, 4-d</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>The <strong>biological indicators</strong> used to check the <strong>efficiency</strong> of various <strong>sterilization </strong>methods are:</p>
<ul>
<li><em>Clostridium tetani</em> - Hot air oven</li>
<li><em>Geobacillus stearothermophilus</em> - Autoclave</li>
<li><em>Bacillus atrophaeus</em> - Ethylene oxide</li>
<li><strong>Bacillus pumilus</strong> - Ionizing radiation</li>
</ul>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 26.6292%;" width="179">
<p><strong>Sterilization technique</strong></p>
</td>
<td style="width: 73.3708%;" width="518">
<p><strong>Bacteria</strong></p>
</td>
</tr>
<tr>
<td style="width: 26.6292%;" width="179">
<p>Hot air oven</p>
</td>
<td style="width: 73.3708%;" width="518">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Spores of <em>Bacillus subtilis subsp. Niger</em> (reclassified as <em>B. atrophaeus</em>)</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Clostridium tetani</em></p>
</td>
</tr>
<tr>
<td style="width: 26.6292%;" width="179">
<p>Autoclave</p>
</td>
<td style="width: 73.3708%;" width="518">
<p><em>Geobacillus stearothermophilus</em></p>
</td>
</tr>
<tr>
<td style="width: 26.6292%;" width="179">
<p>Filtration</p>
</td>
<td style="width: 73.3708%;" width="518">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Serratia marscesens</em></p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Brevundimonas diminuta</em></p>
</td>
</tr>
<tr>
<td style="width: 26.6292%;" width="179">
<p>Ionizing radiation</p>
</td>
<td style="width: 73.3708%;" width="518">
<p><em>Bacillus pumilus</em></p>
</td>
</tr>
<tr>
<td style="width: 26.6292%;" width="179">
<p>Ethylene oxide</p>
</td>
<td style="width: 73.3708%;" width="518">
<p><em>Bacillus globigii (</em>reclassified as <em>B. atrophaeus</em>)</p>
</td>
</tr>
<tr>
<td style="width: 26.6292%;" width="179">
<p>Plasma sterilization</p>
</td>
<td style="width: 73.3708%;" width="518">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Geobacillus stearothermophilus</em></p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Bacillus atrophaeus</em> (<em>Bacillus subtilis subsp. Niger</em>)</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 13</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the following.</strong></p>
<p><strong>1. <img title="image010.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/e2f5f3d5-0135-4d6f-a822-93edf72621fa.jpg" alt="" width="250" height="101" /></strong></p>
<p><strong>2. <img title="image009.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/75fd50b5-3de2-4a1e-aa00-3dcb98c2779f.png" alt="" width="263" height="252" />&nbsp;</strong></p>
<p><strong>3. <img title="image012.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/5e306fcb-ccd5-4cca-a477-415d5e8aa129.png" alt="" width="250" height="110" /></strong></p>
<p><strong>4. <img title="image016.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/a3a26631-8c5c-4df9-9092-9551939400e5.jpg" alt="" width="250" height="166" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1 - Deaver's retractor; 2 - Morris retractor; 3 - Doyen's retractor; 4 - Czerney's retractor</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1 - Deaver's retractor; 2 - Doyen's retractor; 3 - Morris retractor; 4 - Czerney's retractor</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1 - Czerney's retractor; 2 - Deaver's retractor; 3 - Morris retractor; 4 - Deaver's retractor</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1 - Czerney's retractor; 2 - Deaver's retractor; 3 - Doyen's retractor; 4 - Morris retractor</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>The correctly matched options are <strong>1 - Deaver's retractor; 2 - Doyen's retractor; 3 - Morris retractor; 4 - Czerney's retractor. </strong></p>
<ul>
<li><strong>Deaver's Retractor</strong> is specifically designed for holding the liver up out of the way during a cholecystectomy. It needs to be used carefully to avoid damaging the liver.</li>
</ul>
<p><img title="image013.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/0c463dfc-51c1-494a-875e-705cac1d5a61.png" alt="" width="250" height="101" /></p>
<ul>
<li><strong>Doyen's retractor</strong> - It is used to pull back the soft tissues and widen the surgical field during laparotomy.</li>
</ul>
<p><img title="image014.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/d75dbec5-0c32-4bca-ac78-69255c64104f.png" alt="" width="250" height="240" /></p>
<ul>
<li><strong>Morris Retractor</strong> is a big retractor which is useful for giving maximum exposure in large incisions such as those used in the abdomen. It can be used to improve visibility on one side of an incision (by pulling firmly in that direction); so is valuable during the initial phase of a <strong>laparotomy.</strong></li>
</ul>
<p><strong><img title="image015.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/478f11c7-9335-4706-bbc7-77fae375d38d.png" alt="" width="250" height="110" /></strong></p>
<ul>
<li><strong>Czerney's retractor</strong> &ndash; is a <strong>double-ended retractor</strong> used to retract wound edges for <strong>intermediate-type procedures</strong>. It has two spikes on one end and a broad surface on the other. To facilitate insertion of the first mass closure stitch during closure of a midline laparotomy wound by retracting the superior or inferior edges.</li>
</ul>
<p><img title="image016.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/ac9ebaf6-80ae-4980-a22a-25003d89c299.jpg" alt="" width="250" height="166" /></p>
<p><strong>Double hook retractor</strong> is used:</p>
<ul>
<li>To retract skin flap for excision of sebaceous cyst.</li>
<li>During venesection for retraction of skin.</li>
<li>During tracheostomy for retraction of skin and thyroid isthmus.</li>
</ul>
<p><img title="image017.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/c09a7222-f4c4-4abc-b494-1dde2a92a810.jpg" alt="" width="274" height="81" /></p>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 14</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the following:</strong></p>
<ol style="list-style-type: lower-alpha;">
<li>First-degree heart block</li>
<li>Mobitz type 1 heart block</li>
<li>Mobitz type 2 heart block</li>
<li>Complete heart block</li>
</ol>
<p><img title="image018.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/072cdf69-4a1b-4b86-8f08-17ace9b7103c.jpg" alt="" width="260" height="80" /></p>
<p><img title="image019.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/2458932d-2ae9-4bf0-acf3-4c218836648e.jpg" alt="" width="257" height="76" /></p>
<p><img title="image021.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/3cdec492-e801-447a-a26d-f1c1df33f511.jpg" alt="" width="257" height="76" /></p>
<p><img title="image020.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/75e97b3f-b743-48f7-a598-7259e7661bb3.jpg" alt="" width="259" height="84" /></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1- a, 2-c, 3-b, 4- d</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1- c, 2- a, 3- d, 4- b</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1- b, 2- d, 3- c, 4- a</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1- d, 2- b, 3- a, 4- c</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>The correctly matched pairs are <strong>1- c, 2- a, 3- d, and 4- b.</strong></p>
<ul>
<li>The different types of heart blocks are:</li>
<li><strong>First Degree Heart Block:</strong> It occurs due to <strong>slowing of conduction</strong> through the AV junction. It is characterized by prolonged <strong>PR &gt; 0.2s</strong> and <strong>equal RR</strong></li>
</ul>
<p><img title="image022.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/86ae103f-82b4-4c38-b5e2-f730d014f808.jpg" alt="" width="290" height="116" /></p>
<ul>
<li><strong>Second Degree Heart Block:</strong> It occurs due to the intermittent failure of electrical impulse conduction from the atrium to the ventricle. It is characterized by a missed QRS. It is of two types:</li>
<li><strong>Mobitz type 1/ Wenckebach</strong> occurs due to the decremental conduction of electrical impulses in the AV node. It is characterized by a progressive PR elongation leading to an eventual drop in the QRS complex. This may be seen in young athletes.</li>
</ul>
<p><img title="image023.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/3e0098f1-5fff-45ac-9446-a82c806d50b6.jpg" alt="" width="324" height="101" /></p>
<ul>
<li><strong>Mobitz type 2</strong> occurs in the distal or infra-His conduction system and is often associated with intraventricular conduction delays. It is characterized by an intermittent failure of conduction of the p wave without any change in the preceding impulses. On ECG there&nbsp;</li>
</ul>
<p><img title="image024.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/126ef8c8-a5c3-4f84-a33c-158cc420dce3.jpg" alt="" width="334" height="99" /></p>
<p><strong>Third Degree Heart Block/Complete Heart Block:&nbsp; </strong>It occurs when none of the impulses from the atria are conducted to the ventricles. It is characterized by:</p>
<ul>
<li>Escape rhythm</li>
<li>RR equal, PP equal</li>
<li>P waves &gt; QRS waves</li>
<li>No relationship between P and QRS</li>
</ul>
<p><img title="image025.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/7a4c6907-6795-4ebd-9679-d47a1cb6887c.jpg" alt="" width="335" height="95" /></p>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 15</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Correctly match the following logos.</strong></p>
<p><strong><img title="image026.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/43302d78-e2d8-4b21-b4f6-01bcfe255122.jpg" alt="" width="359" height="155" /></strong></p>
<p>a. Cytotoxic</p>
<p>b. Radiation</p>
<p>c. Biohazard</p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-c, 2-b, 3-a</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-c, 2-a, 3-b</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-a, 2-b, 3-c</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-b, 2-a, 3-c</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>The correctly matched logos are as shown below.&nbsp;</p>
<p><img title="image027.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/d542812f-52ab-4343-be57-9dd9d15f9f77.jpg" alt="" width="410" height="177" /></p>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 16</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the descriptions or possible etiologies with the appropriate abnormal assessment findings.</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 45.648%;" width="292">
<p><strong>Column-A </strong></p>
</td>
<td style="width: 54.352%;" width="349">
<p><strong>Column-B </strong></p>
</td>
</tr>
<tr>
<td style="width: 45.648%;" width="292">
<p>A.&nbsp;&nbsp; Finger clubbing</p>
<p>B.&nbsp;&nbsp;&nbsp; Stridor</p>
<p>C.&nbsp;&nbsp;&nbsp; Wheezes</p>
<p>D.&nbsp;&nbsp; Hyperresonance</p>
</td>
<td style="width: 54.352%;" width="349">
<p>1)&nbsp;&nbsp;&nbsp; Air trapping</p>
<p>2)&nbsp;&nbsp;&nbsp; Bronchoconstriction</p>
<p>3)&nbsp;&nbsp;&nbsp; Partial obstruction of trachea or larynx</p>
<p>4)&nbsp;&nbsp;&nbsp; Chronic hypoxemia</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-1, B-2, C-3, D-4</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-4, B-3, C-2, D-1</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-3, B-4, C-2, D-1</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-4, B-3, C-1, D-2</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li><strong>Finger clubbing - Chronic hypoxemia</strong>: Finger clubbing is often associated with <strong>chronic hypoxemia</strong>, as seen in conditions like chronic obstructive pulmonary disease (COPD), interstitial lung disease, or congenital heart defects.</li>
<li><strong>Stridor - Partial obstruction of the trachea or larynx</strong>: Stridor is a high-pitched sound caused by <strong>partial obstruction</strong> in the upper airway, such as due to laryngeal edema, foreign body, or tumor.</li>
<li><strong>Wheezes - Bronchoconstriction</strong>: Wheezes are caused by <strong>bronchoconstriction</strong>, which occurs in conditions like asthma or chronic bronchitis. It indicates narrowing of the airways.</li>
<li><strong>Hyperresonance - Air trapping</strong>: Hyperresonance on percussion suggests <strong>air trapping</strong>, commonly observed in emphysema or severe asthma, where air gets trapped in the lungs during expiration</li>
</ul>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 43.3269%;" width="246">
<p><strong>Etiology </strong></p>
</td>
<td style="width: 56.6731%;" width="331">
<p><strong>Abnormal easements findings </strong></p>
</td>
</tr>
<tr>
<td style="width: 43.3269%;" width="246">
<p>Finger clubbing</p>
</td>
<td style="width: 56.6731%;" width="331">
<p>Chronic hypoxemia</p>
</td>
</tr>
<tr>
<td style="width: 43.3269%;" width="246">
<p>Stridor</p>
</td>
<td style="width: 56.6731%;" width="331">
<p>Partial obstruction of trachea or larynx</p>
</td>
</tr>
<tr>
<td style="width: 43.3269%;" width="246">
<p>Wheezes</p>
</td>
<td style="width: 56.6731%;" width="331">
<p>Bronchoconstriction</p>
</td>
</tr>
<tr>
<td style="width: 43.3269%;" width="246">
<p>Pleural friction rub</p>
</td>
<td style="width: 56.6731%;" width="331">
<p>Pleurisy</p>
</td>
</tr>
<tr>
<td style="width: 43.3269%;" width="246">
<p>Increased tactile fremitus</p>
</td>
<td style="width: 56.6731%;" width="331">
<p>Lung consolidation with fluid or exudate</p>
</td>
</tr>
<tr>
<td style="width: 43.3269%;" width="246">
<p>Hyperresonance</p>
</td>
<td style="width: 56.6731%;" width="331">
<p>Air trapping</p>
</td>
</tr>
<tr>
<td style="width: 43.3269%;" width="246">
<p>Fine crackles</p>
</td>
<td style="width: 56.6731%;" width="331">
<p>Interstitial filling with fluid</p>
</td>
</tr>
<tr>
<td style="width: 43.3269%;" width="246">
<p>Absent breath sounds</p>
</td>
<td style="width: 56.6731%;" width="331">
<p>Atelectasis</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 17</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>You administer gentamycin injection to a patient. Where do you discard the waste used in this process?</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 38.1044%;" width="180">
<p><strong>Column-A</strong></p>
</td>
<td style="width: 61.8956%;" width="302">
<p><strong>Column-B</strong></p>
</td>
</tr>
<tr>
<td style="width: 38.1044%;" width="180">
<p>1)&nbsp;&nbsp;&nbsp; Yellow</p>
<p>2)&nbsp;&nbsp;&nbsp; Red</p>
<p>3)&nbsp;&nbsp;&nbsp; Blue</p>
<p>4)&nbsp;&nbsp;&nbsp; White</p>
</td>
<td style="width: 61.8956%;" width="302">
<p>a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Antibiotic vial</p>
<p>b.&nbsp;&nbsp;&nbsp;&nbsp; Syringe's needle</p>
<p>c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cotton swab</p>
<p>d.&nbsp;&nbsp;&nbsp;&nbsp; Syringes</p>
<p>e.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diluent bottle</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-c, 2-d, 3-a, 4-e</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-d, 2-c, 3-e, 4-a</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-c, 2-a, 3-d, 4-b</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1-c, 2-e, 3-a, 4-b</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>The correctly matched color-coded bins and biomedical waste are as follows:</p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 40.619%;" width="217">
<p><strong>Color-coded bin</strong></p>
</td>
<td style="width: 59.381%;" width="331">
<p><strong>Biomedical waste</strong></p>
</td>
</tr>
<tr>
<td style="width: 40.619%;" width="217">
<p>Yellow</p>
</td>
<td style="width: 59.381%;" width="331">
<p>Cotton swab</p>
</td>
</tr>
<tr>
<td style="width: 40.619%;" width="217">
<p>Red</p>
</td>
<td style="width: 59.381%;" width="331">
<p>Syringes and diluent bottle- plastic</p>
</td>
</tr>
<tr>
<td style="width: 40.619%;" width="217">
<p>Blue</p>
</td>
<td style="width: 59.381%;" width="331">
<p>Antibiotic vial- glass</p>
</td>
</tr>
<tr>
<td style="width: 40.619%;" width="217">
<p>White transparent</p>
</td>
<td style="width: 59.381%;" width="331">
<p>Syringe's needle</p>
</td>
</tr>
</tbody>
</table>
<p><strong>Biomedical waste disposal</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 22.4371%;" width="132">
<p><strong>Color-coded bin</strong></p>
</td>
<td style="width: 32.3017%;" width="283">
<p><strong>Type of Waste</strong></p>
</td>
<td style="width: 45.0677%;" width="302">
<p><strong>Treatment and Disposal Options</strong></p>
</td>
</tr>
<tr>
<td style="width: 22.4371%;" rowspan="7" width="132">
<p><strong>Yellow bag</strong> (non-chlorinated)</p>
</td>
<td style="width: 32.3017%;" width="283">
<p><strong>Human anatomical waste</strong></p>
<p><strong>Animal anatomical waste</strong></p>
</td>
<td style="width: 45.0677%;" width="302">
<p><strong>Incineration</strong>/Plasma pyrolysis/Deep Burial</p>
<p>&nbsp;</p>
</td>
</tr>
<tr>
<td style="width: 32.3017%;" width="283">
<p><strong>Soiled Waste:</strong> Items like dressings, cotton swabs, and plaster casts contaminated with blood and body fluids and bags containing residual discarded blood.</p>
</td>
<td style="width: 45.0677%;" width="302">
<p><strong>Incineration</strong>/Plasma pyrolysis/Deep Burial</p>
<p>or</p>
<p>Autoclaving/Microwaving/ Hydroclaving</p>
<p>Later - Shredding/mutilation</p>
</td>
</tr>
<tr>
<td style="width: 32.3017%;" width="283">
<p>Discarded linen, mattresses, beddings contaminated with blood or body fluid, <strong>routine masks, and gowns</strong></p>
</td>
<td style="width: 45.0677%;" width="302">
<p>Non- chlorinated chemical disinfection followed by incineration or plasma</p>
<p>Pyrolysis or for energy recovery.</p>
<p>In absence of the above facilities, shredding, mutilation, or a combination of sterilization and shredding is used.</p>
</td>
</tr>
<tr>
<td style="width: 32.3017%;" width="283">
<p><strong>Microbiology, biotechnology, clinical laboratory waste</strong></p>
<p>(Autoclave safe plastic bags used)</p>
<p><strong>Blood bags,</strong> laboratory cultures, stocks or specimens of microorganisms, live or attenuated vaccines, human and animal cell cultures used in research, industrial laboratories, production of biological, residual toxins, dishes, and devices used for cultures.</p>
</td>
<td style="width: 45.0677%;" width="302">
<p>&nbsp;</p>
<p>Pre-treatment with nonchlorinated chemicals</p>
<p>Later - Incineration</p>
<p>&nbsp;</p>
</td>
</tr>
<tr>
<td style="width: 32.3017%;" width="283">
<p>Expired/discarded medicine, cytotoxic drugs</p>
</td>
<td style="width: 45.0677%;" width="302">
<p>Incineration/plasma pyrolysis/ disposal in a secured landfill</p>
</td>
</tr>
<tr>
<td style="width: 32.3017%;" width="283">
<p><strong>Chemical waste</strong></p>
<p>Chemicals used in biological production and used or discarded disinfectants.</p>
</td>
<td style="width: 45.0677%;" width="302">
<p>Disposal- incineration/plasma pyrolysis</p>
<p>Encapsulation- hazardous waste treatment, storage, and disposal facility.</p>
</td>
</tr>
<tr>
<td style="width: 32.3017%;" width="283">
<p><strong>Chemical liquid waste:</strong></p>
<p>Liquid waste generated due to the use of chemicals in the production of biological, used or <strong>discarded disinfectants</strong>, silver X-ray film, developing liquid, discarded formalin,</p>
</td>
<td style="width: 45.0677%;" width="302">
<p>After resource recovery, the chemical liquid waste shall be pre-treated before mixing with other wastewater.</p>
</td>
</tr>
<tr>
<td style="width: 22.4371%;" width="132">
<p><strong>Red bag (non-chlorinated)</strong></p>
</td>
<td style="width: 32.3017%;" width="283">
<p><strong>Recyclable contaminated</strong> waste</p>
<p>&nbsp;</p>
<p>Contaminated waste tubing, bottles, intravenous tubes and sets, <strong>catheters, urine bags</strong>, syringes (without needles and fixed needle syringes with their needles cut), <strong>vacutainers with needles cut</strong>, and gloves.</p>
</td>
<td style="width: 45.0677%;" width="302">
<p><strong>Autoclaving/Microwaving/ Hydroclaving</strong></p>
<p>&nbsp;</p>
<p>Followed by Shredding/mutilation</p>
<p>&nbsp;</p>
<p>And later, Energy recovery/Plastics to diesel or fuel oil/road-making</p>
<p>&nbsp;</p>
<p>Not to be sent to landfill</p>
</td>
</tr>
<tr>
<td style="width: 22.4371%;" width="132">
<p><strong>White (translucent)</strong></p>
<p>(puncture-proof, leak-proof containers)</p>
</td>
<td style="width: 32.3017%;" width="283">
<p><strong>Waste sharps including metals.</strong></p>
<p>&nbsp;</p>
<p>Needles, syringes with fixed needles, needles from needle tip cutter or burner, scalpels, blades, or any other <strong>contaminated sharp</strong> object that may cause puncture and cuts. This includes both used/ discarded, and contaminated metal sharps</p>
</td>
<td style="width: 45.0677%;" width="302">
<p>Autoclaving/Dry heat sterilization</p>
<p>&nbsp;</p>
<p>Followed by - <strong>Shredding/mutilation/</strong> encapsulation</p>
<p>&nbsp;</p>
<p>Later by - Iron foundries/sanitary landfill/waste sharps</p>
<p>&nbsp;</p>
</td>
</tr>
<tr>
<td style="width: 22.4371%;" width="132">
<p><strong>Blue</strong></p>
<p>(Puncture proof and leak proof containers with blue colored marking)</p>
</td>
<td style="width: 32.3017%;" width="283">
<p><strong>Glassware</strong></p>
<p>Broken or discarded and contaminated glass including medicine <strong>vials </strong>and <strong>ampules except</strong> those containing <strong>cytotoxic</strong> waste.</p>
<p>&nbsp;</p>
<p><strong>Metallic body implants</strong></p>
</td>
<td style="width: 45.0677%;" width="302">
<p>Sodium hypochlorite/Autoclaving/ Microwaving/Hydroclaving</p>
<p>&nbsp;</p>
<p>Later - Recycling</p>
<p>&nbsp;</p>
</td>
</tr>
</tbody>
</table>
<p><strong>Note:</strong> <strong>Ash</strong> from the <strong>incineration</strong> of biomedical waste shall be disposed of at a <strong>common hazardous waste treatment and disposal facility.</strong> However, it may also be disposed of in a <strong>municipal landfill,</strong> if the toxic metals in incineration ash are <strong>within</strong> the <strong>regulatory quantities</strong> as defined under the Hazardous Waste (Management and Handling and Transboundary Movement) Rules, 2008 as amended from time to time.</p>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 18</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the surgical procedures with their primary purposes in cancer treatment.</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 56.0928%;" width="369">
<p><strong>Column-A</strong></p>
</td>
<td style="width: 43.9072%;" width="274">
<p><strong>Column-B</strong></p>
</td>
</tr>
<tr>
<td style="width: 56.0928%;" width="369">
<p>A.&nbsp;&nbsp; Mammoplasty</p>
<p>B.&nbsp;&nbsp;&nbsp; Debulking procedure to enhance radiation therapy &nbsp;&nbsp;</p>
<p>C.&nbsp;&nbsp;&nbsp; Placement of a central venous catheter</p>
<p>D.&nbsp;&nbsp; Colostomy to bypass bowel obstruction</p>
</td>
<td style="width: 43.9072%;" width="274">
<p>1)&nbsp;&nbsp;&nbsp; Cure, control, or both</p>
<p>2)&nbsp;&nbsp;&nbsp; Supportive care</p>
<p>3)&nbsp;&nbsp;&nbsp; Palliation</p>
<p>4)&nbsp;&nbsp;&nbsp; Rehabilitation</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-3, B-4, C-1, D-2</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-4, B-1, C-2, D-3</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-4, B-3, C-2, D-1</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-1, B-2, C-3, D-4</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li><strong>Mammoplasty</strong>: This procedure is primarily performed for <strong>rehabilitation</strong> after a mastectomy, aiming to restore the breast shape.</li>
<li><strong>Debulking procedure to facilitate radiation therapy</strong>: A <strong>debulking procedure</strong> is used to remove as much of the tumor as possible to improve the effectiveness of radiation or other therapies. This is typically done for <strong>curing or controlling cancer</strong>.</li>
<li><strong>(Insertion of a central venous catheter</strong>: This procedure is part of <strong>supportive care</strong>, providing access for treatments like chemotherapy or nutrition support.</li>
<li><strong>Colostomy to bypass bowel obstruction</strong>: A <strong>colostomy</strong> is a palliative procedure to manage bowel obstruction, relieving symptoms and improving quality of life for the patient.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 19</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the following descriptions with the mechanisms of fluid and electrolyte movement.</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 59.1876%;" width="369">
<p><strong>Column-A </strong></p>
</td>
<td style="width: 40.8124%;" width="246">
<p><strong>Column-B </strong></p>
</td>
</tr>
<tr>
<td style="width: 59.1876%;" width="369">
<p>A.&nbsp;&nbsp; Adenosine triphosphate (ATP) required</p>
<p>B.&nbsp;&nbsp;&nbsp; Uses a carrier molecule</p>
<p>C.&nbsp;&nbsp;&nbsp; Pressure exerted by proteins</p>
<p>D.&nbsp;&nbsp; Flow of water from low-solute concentration to high-solute concentration</p>
</td>
<td style="width: 40.8124%;" width="246">
<p>1)&nbsp;&nbsp;&nbsp; Osmosis</p>
<p>2)&nbsp;&nbsp;&nbsp; Active transport</p>
<p>3)&nbsp;&nbsp;&nbsp; Oncotic pressure</p>
<p>4)&nbsp;&nbsp;&nbsp; Facilitated diffusion</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-4, B-2, C-3, D-1</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-2, B-4,C-3, D-1</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-3, B-4, C-2, D-1</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-3, B-2, C-1, D-4</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li><strong>Requires adenosine triphosphate - ATP</strong>: This refers to <strong>active transport</strong>, where energy in the form of ATP is required to move molecules across a membrane against their concentration gradient.</li>
<li><strong>Uses a carrier molecule</strong>: This describes <strong>facilitated diffusion</strong>, where a carrier molecule helps transport substances across a cell membrane without energy expenditure.</li>
<li><strong>Pressure exerted by proteins</strong>: This corresponds to <strong>oncotic pressure</strong>, which is the pressure exerted by proteins (particularly albumin) in a solution, influencing fluid movement.</li>
<li><strong>Flow of water from low-solute concentration to high-solute concentration</strong>: This is the mechanism of <strong>osmosis</strong>, where water moves through a semipermeable membrane from an area of low solute concentration to high solute concentration.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 20</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the electrolyte imbalances with their associated causes.</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 50.4836%;" width="273">
<p><strong>Column-A </strong></p>
</td>
<td style="width: 49.5164%;" width="265">
<p><strong>Column-B </strong></p>
</td>
</tr>
<tr>
<td style="width: 50.4836%;" width="273">
<p>A.&nbsp;&nbsp; Alcohol withdrawal</p>
<p>B.&nbsp;&nbsp;&nbsp; Metabolic alkalosis</p>
<p>C.&nbsp;&nbsp;&nbsp; Parathyroidectomy</p>
<p>D.&nbsp;&nbsp; Diabetes insipidus</p>
<p>E.&nbsp;&nbsp;&nbsp; Early burn stage</p>
</td>
<td style="width: 49.5164%;" width="265">
<p>1)&nbsp;&nbsp;&nbsp; Hypophosphatemia</p>
<p>2)&nbsp;&nbsp;&nbsp; Hypokalemia</p>
<p>3)&nbsp;&nbsp;&nbsp; Hypocalcemia</p>
<p>4)&nbsp;&nbsp;&nbsp; Hypernatremia</p>
<p>5)&nbsp;&nbsp;&nbsp; Hyperkalemia</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-1, B-2, C-3, D-4, E-5</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-5, B-4, C-3, D-2, E-1</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-2, B-3, C-1, D-4, E-5</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-1, B-2, C-4, D-3, E-5</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li><strong>Alcohol withdrawal</strong>: Alcohol withdrawal can cause <strong>hypophosphatemia</strong>, as the body uses phosphate to metabolize alcohol, leading to a deficiency of phosphorus during withdrawal.</li>
<li><strong>Metabolic alkalosis</strong>: <strong>Metabolic alkalosis</strong> often leads to <strong>hypokalemia</strong>, as the body compensates for the alkalosis by shifting potassium into cells, reducing serum potassium levels.</li>
<li><strong>Parathyroidectomy</strong>: Following a <strong>parathyroidectomy</strong>, there is a risk of <strong>hypocalcemia</strong> due to the loss of parathyroid hormone, which is essential for calcium regulation.</li>
<li><strong>Diabetes insipidus</strong>: <strong>Diabetes insipidus</strong> results in excessive urination and can lead to <strong>hypernatremia</strong>, as water loss causes an increase in serum sodium concentration.</li>
<li><strong>Early stage of burns</strong>: In the early stages of burns, <strong>hyperkalemia</strong> may occur due to cell injury and the release of potassium from damaged cells into the bloodstream.</li>
</ul>
</body>
</html></li></ul></div></div>
        <div class="credits">
            <p class="rainbow-text">Credit: Code Written by BHASKAR</p>
        </div>
        </body></html>